Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2007-10-31Clinical Trial Update: Iscar for Second Line Treatment of Advanced Non-Small Cell Lung Cancer [NA]
A completed clinical trial update for Iscar as a second-line treatment for advanced non-small cell lung cancer. The study identifier is NCT0…
-
CLINICAL_TRIALS trial_result · 2007-08-21Clinical Trial Update: Subcutaneous Amifostine (Ethyol®) in the Prevention of Radiochemotherapy-Induced Esophagitis and Pneumonitis in Patients With Unresectable Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated subcutaneous amifostine (Ethyol) for preventing radiochemotherapy-induced esophagitis and pneumonitis in patients …
-
CLINICAL_TRIALS trial_result · 2007-08-14Clinical Trial Update: Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects With Non-Small Cell Lung Cancer (NSCLC) [Phase 2]
A Phase 2 trial evaluating ABT-510 in combination with chemotherapy for non-small cell lung cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2007-07-30Clinical Trial Update: Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Iressa (gefitinib) as first-line therapy in chemonaive patients with inoperable non-small cell lung cancer has be…
-
CLINICAL_TRIALS trial_result · 2007-06-25Clinical Trial Update: Trial of Perioperative Chemotherapy (Gemcitabine and Cisplatin) and Adjuvant Chemoradiotherapy (With Weekly Low Dose Gemcitabine) in Patients With Lung Cancer With Positive Nodes [Phase 2]
A Phase 2 trial evaluating perioperative gemcitabine/cisplatin plus adjuvant chemoradiotherapy with weekly gemcitabine in node-positive non-…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Trial of Pemetrexed or Pemetrexed With Gemcitabine for Patients With Advanced Lung Cancer Who Are Not Eligible for Platinum-Based Chemotherapy and Have Not Previously Been Treated With Chemotherapy [Phase 2]
A completed Phase 2 trial evaluating pemetrexed alone or in combination with gemcitabine in patients with advanced non-small cell lung cance…
-
CLINICAL_TRIALS trial_result · 2007-06-22Clinical Trial Update: Trial Comparing 3 and 4 Week Regimen of Gemcitabine and Cisplatin in Patients With Lung Cancer [Phase 2]
Phase 2 trial comparing 3-week and 4-week regimens of gemcitabine plus cisplatin in non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study NCT00080080 evaluating talabostat in combination with docetaxel in advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Study of Talabostat and Pemetrexed vs. Pemetrexed in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy [Phase 3]
Phase 3 trial comparing talabostat plus pemetrexed versus pemetrexed alone in Stage IIIB/IV non-small cell lung cancer after platinum-based …
-
CLINICAL_TRIALS trial_result · 2007-06-08Clinical Trial Update: Study of Talabostat + Docetaxel Versus Docetaxel in Stage IIIB/IV Non-Small Cell Lung Cancer (NSCLC) After Failure of Platinum-Based Chemotherapy [Phase 3]
A Phase 3 trial comparing talabostat plus docetaxel to docetaxel alone in patients with stage IIIB/IV non-small cell lung cancer after plati…
-
CLINICAL_TRIALS trial_result · 2007-05-08Clinical Trial Update: Study of Neurologic Progression With Motexafin Gadolinium and Radiation Therapy (SMART) [Phase 3]
A Phase 3 trial (SMART) evaluating motexafin gadolinium with radiation therapy for brain neoplasms and non-small cell lung cancer has comple…
-
CLINICAL_TRIALS trial_result · 2007-05-07Clinical Trial Update: Study of DN101 and Taxotere in Patients With Advanced Non-Small Cell Lung Cancer [Phase 1, Phase 2]
This clinical trial update reports results from Phase 1 and Phase 2 studies evaluating DN101 in combination with Taxotere (docetaxel) for pa…
-
CLINICAL_TRIALS trial_result · 2007-05-04Clinical Trial Update: A Multicenter Phase 2 Study of CI-1040 in Patients With Advanced Nonsmall-Cell Lung, Breast, Colon and Pancreatic Cancer [Phase 2]
Pfizer conducted a multicenter Phase 2 trial of CI-1040 in patients with advanced colorectal cancer, breast cancer, non-small cell lung canc…
-
CLINICAL_TRIALS trial_result · 2007-05-01Clinical Trial Update: Enzastaurin as Second and Third-Line Treatment for Non-Small Cell Lung Cancer. [Phase 2]
Enzastaurin was studied as a second- or third-line treatment for non-small cell lung cancer in a Phase 2 trial, which has completed.
-
CLINICAL_TRIALS trial_result · 2007-04-27Clinical Trial Update: Phase II Trial of Tarceva in Patients With Non-Small Cell Lung Cancer [Phase 2]
This document provides an update on a Phase II trial of Tarceva (erlotinib) in non-small cell lung cancer, with the current status of the tr…
-
CLINICAL_TRIALS trial_result · 2007-04-23Clinical Trial Update: Fluorine-18-α-Methyltyrosine Positron Emission Tomography for Diagnosis and Staging of Lung Cancer
This completed clinical trial evaluated the diagnostic and staging utility of Fluorine-18-α-Methyltyrosine PET imaging in non-small cell lun…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Efficacy Trial of Gemcitabine Containing Regimens As Preoperative Chemotherapy in Non Small Cell Lung Cancer [Phase 2]
Phase 2 trial evaluating gemcitabine-containing regimens as preoperative chemotherapy for non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Study Comparing Short Infusion Vs. Fixed Dose of Cisplatin + Gemcitabine in Non Small Cell Lung Cancer. [Phase 2]
A Phase 2 trial comparing short infusion versus fixed-dose administration of cisplatin plus gemcitabine in non-small cell lung cancer has co…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Single Arm Phase 2 Study of Pemetrexed as 2nd-Line Treatment of Advanced Non-Small Cell Lung Cancer [Phase 2]
A single-arm Phase 2 trial evaluated pemetrexed as second-line therapy for advanced non-small cell lung cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Gemcitabine/Platinum Containing Regimens as Preoperative Chemotherapy for Patients With Non Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluated gemcitabine/platinum-containing regimens as preoperative chemotherapy for patients with non-small cell lu…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Safety and Pharmacokinetics of Jin Fu Kang in Comb w/Docetaxel for Patients w/Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study evaluating safety and pharmacokinetics of Jin Fu Kang in combination with docetaxel for non-small cell lung cancer has complet…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: A Randomized Study Evaluating the Feasibility and Activity of Three Different Combination With Gemcitabine as First Line Therapy for Non Small Cell Lung Cancer [Phase 2]
A Phase 2 randomized study evaluated three different gemcitabine-based first-line combinations for non-small cell lung cancer, reporting fea…
-
CLINICAL_TRIALS trial_result · 2007-01-26Clinical Trial Update: Pemetrexed and Gemcitabine in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC) [Phase 1, Phase 2]
Phase 1/2 trial evaluating the combination of pemetrexed and gemcitabine in patients with advanced non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-20Clinical Trial Update: A Study to Evaluate the Single-Agent Lenalidomide in Subjects With Recurrent Non-Small-Cell Lung Cancer [Phase 2]
Phase 2 study evaluating single-agent lenalidomide in subjects with recurrent non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2006-12-06Clinical Trial Update: Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer [Phase 1]
This Phase 1 trial update reports safety and immunogenicity data for a recombinant DNA and adenovirus expressing the L523S protein in patien…